Text Size
27 studies found for:    " March 17, 2010":" April 16, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Not yet recruiting Adherence to HIV Therapy in Heroin Addicts
Conditions: HIV;   Substance Abuse;   HIV Infections
Interventions: Drug: Oral Naltrexone (ON);   Drug: Implantable Naltrexone (IN)
2 Active, not recruiting
Has Results 		Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: Stribild;   Drug: ATV/r + Truvada
3 Active, not recruiting
Has Results 		Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: Stribild;   Drug: Atripla
4 Completed
Has Results 		Study of Vitamin D and Effect on Heart Disease and Insulin Resistance
Conditions: HIV;   Vitamin D Deficiency;   HIV Infections
Intervention: Drug: Vitamin D
5 Completed Project POWER, Adapting Project SAFE: Reducing STD/HIV Risk in Women Prisoners
Condition: HIV Infections
Interventions: Behavioral: Project POWER HIV Risk-reduction Intervention;   Behavioral: NC DOC Standard of Care for STIs
6 Completed Vitamin D Dose Finding Study
Conditions: HIV Infections;   AIDS
Intervention: Drug: Cholecalciferol (Vit D3)
7 Completed H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected Patients
Condition: HIV Infections
Intervention: Biological: H1N1 vaccination
8 Recruiting Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine
Condition: HIV Infections
Intervention: Procedure: Blood collection
9 Enrolling by invitation Mesalamine to Reduce T Cell Activation in HIV Infection
Conditions: HIV Infections;   Sexually Transmitted Diseases;   Immune System Diseases;   Lentivirus Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Mesalamine (5-aminosalicylic acid, Apriso);   Drug: Placebo
10 Unknown † Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Raltegravir;   Drug: Atazanavir/Ritonavir
11 Completed GSK1349572 Relative Bioavailability Study
Condition: HIV Infections
Interventions: Drug: GSK1349572 formulation AP;   Drug: GSK1349572 formulation AW;   Drug: GSK1349572 formulation AX
12 Completed HIV Fat Redistribution and the Evaluation of Brown Fat
Condition: HIV Infections
Intervention:
13 Enrolling by invitation Test of an Intervention to Improve HIV Care
Condition: HIV Infection
Interventions: Behavioral: Patient Mentor Intervention;   Behavioral: HIV transmission risk reduction
14 Active, not recruiting Evaluating Heterologous-Insert Prime-Boost HIV Vaccine Regimens in HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: rAd35 Env A;   Biological: rAd5 Env A;   Biological: rAd5 Env B
15 Active, not recruiting PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV)
Condition: HIV Infections
Interventions: Drug: Atazanavir;   Drug: Ritonavir
16 Active, not recruiting Evaluating the Safety and Immune Response of an Adenovirus-Based HIV Vaccine in HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: Ad26.ENVA.01 (rAd26);   Biological: Placebo Vaccine
17 Active, not recruiting
Has Results 		A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Reyataz + Norvir + Truvada;   Drug: Reyataz + Epzicom
18 Recruiting Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects
Conditions: Birth Defects;   Infection, Human Immunodeficiency Virus
Intervention: Drug: Any Antiretroviral Therapy
19 Completed A Drug Interaction Study Evaluating GSK2248761 and Raltegravir Pharmacokinetics in Healthy Adult Subjects
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: GSK2248761;   Drug: GSK2248761 + Raltegravir
20 Recruiting Cardiovascular Radiologic and Metabolic Assessment in HIV: An Investigation of Pathophysiology
Conditions: HIV;   Cardiovascular Disease
Intervention:
To Top

Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results
† Indicates status has not been verified in more than two years